Analysts raise price targets for Amgen and Amylyx

Statements (5)

1. ▲ Bullish

   Guggenheim raised its price target on Amylyx Pharmaceuticals, Inc. (AMLX) to $40 from $30

   finance.yahoo.comJun 30, 2026 13:09 UTC
2. ▲ Bullish

   Amgen Inc. is likely to see its stock price rise following the analyst's price target increase to $303.

   finance.yahoo.comJun 24, 2026 13:27 UTC
3. ▲ Bullish

   Mizuho analyst Salim Syed raised the price target for Amgen Inc. to $303 from $295

   finance.yahoo.comJun 24, 2026 13:27 UTC
4. ▼ Bearish

   Canaccord cut its price target on Regeneron Pharmaceuticals from $1,057 to $875

   finance.yahoo.comMay 26, 2026 12:44 UTC
5. ● Neutral

   Guggenheim lowered its price target for Amgen from $351 to $340

   247wallst.comMay 4, 2026 14:50 UTC